Statistics Collaborative - Design and analysis for biomedical research


Rebecca Agnor, M.S.
Biostatistician II

Rebecca Agnor, M.S., joined Statistics Collaborative, Inc. (SCI) in 2016.

At SCI, Ms. Agnor has worked with clinical trials in a range of disease areas, including cardiovascular disease, Alzheimer’s disease, and oncology. In her role as a biostatistician, she performs statistical analyses, programs datasets, generates graphs, tables, and listings, and validates program code.

Prior to joining SCI, Ms. Agnor was a graduate research associate at Rho, Inc., working with clinical trials on autoimmune diseases, including type 1 diabetes, rheumatoid arthritis, and lupus. She also interned at the National Cancer Institute where she was involved in research on randomization methods for clinical trials.

She received her B.A. summa cum laude in Mathematics (concentration in statistics) with a minor in Business from Wittenberg University (2014) and her M.S. in Biostatistics from The University of North Carolina-Chapel Hill (2016). Her master’s project was titled “Evaluating imputation methods for values below the limit of detection in type 1 diabetes studies”.